brequinar has been researched along with veliparib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdullah, I; Antony, T; Chee, CF; Lee, YK; Mun, KW; Nellore, K; Othman, S; Rahman, NA; Satish Reddy, K; Subramanya, H; Thunuguntla, SSR; Verma, J | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for brequinar and veliparib
| Article | Year |
|---|---|
Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH.
Topics: Benzimidazoles; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Oxidoreductases Acting on CH-CH Group Donors; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Structure-Activity Relationship | 2015 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |